Stent thrombosis associated with drug eluting stents on addition of cilostazol to the standard dual antiplatelet therapy following percutaneous coronary intervention: a systematic review and meta-analysis of published randomized controlled trials

Table 4 Results of this analysis

Outcomes	OR with 95% CI	P value	I² (%)	Statistical model used
ST	0.65 [0.38–1.10]	0.11	6	Fixed effects
Definite ST	1.18 [0.38–3.69]	0.77	3	Fixed effects
Probable ST	0.75 [0.17–3.35]	0.70	0	Fixed effects
Acute ST	0.48 [0.13–1.74]	0.27	0	Fixed effects
Sub-acute ST	0.56 [0.22–1.40]	0.21	0	Fixed effects
Late ST	0.72 [0.23–2.28]	0.58	0	Fixed effects

Abbreviations: OR: Odds ratios, CI: Confidence intervals, ST: Stent thrombosis, RCT: Randomized controlled trials, OS: Observational studies

ISSN: 2050-6511